Last updated 2026-07-24
- Raised $30M grant, Apr 2005
- Raised $25M Seed round, Dec 2001
Total raised
$55.0M
Last: Grant 2005-05
Stage
Seed
Founded
2019
Headcount
5
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Formulex Pharma Innovations is an Israeli formulation and drug-delivery development company established in April 2019. It provides formulation R&D, analytical support, and small-scale GMP production for clinical-stage programs. The company focuses on solubility/bioavailability enhancement and new delivery routes for APIs across biopharma, nutraceutical, and agrochemical applications. Formulex continues the activities of SoluBest Ltd. in the field of nano-technology based drug delivery and formulation, and has developed over 10 medical cannabis products, with five in clinical and commercial stages.
Funding history · 2 rounds · $55.0M total
2005-04
Grant
$30.0M
2001-12
Seed
$25.0M
Headcount over time
From 8 (2019-03) to 5 (2023-11) · -3 (-37%) · 3 points · source: Finder history + radar grounding
Q&A
- What is Formulex Pharma Innovations' primary focus?
- Formulex Pharma Innovations specializes in nanotechnology-based drug delivery and formulation, providing innovative solutions for clients in biopharmaceuticals, nutraceuticals, and agrochemicals.
- How many employees does Formulex Pharma Innovations have?
- Formulex Pharma Innovations has 1-10 employees.
- What is the total amount of funding Formulex Pharma Innovations has raised?
- Formulex Pharma Innovations has raised a total of $55,000,000.
- When was Formulex Pharma Innovations founded?
- Formulex Pharma Innovations was founded in July 2001.
- Does Formulex Pharma Innovations have any patents?
- Yes, Formulex Pharma Innovations holds patents, including for its Solumer technology.
- What is the Solumer technology developed by Formulex Pharma Innovations?
- Solumer is a patented technology developed by Formulex Pharma Innovations (formerly SoluBest) to maximize the solubility, bioavailability, and physical stability of drug substances through sub-micron-particle engineering and proprietary spray drying processes.
- What types of products has Formulex Pharma Innovations developed using its technology?
- Formulex Pharma Innovations has developed over 10 medical cannabis products using its patented Solumer and generic technologies, with five products currently in clinical and commercial stages.
- What dosage forms can Formulex Pharma Innovations develop and produce?
- Formulex Pharma Innovations can develop and produce oral, topical, and inhaled dosage forms under GMP conditions for clinical phases one and two.
Team · 1
Dr. Galia Temtsin Krayz
Founder · Chief Executive Officer and Head of R&D
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug Delivery
Technologies
Materials & SubstancesRaw MaterialsBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
nanotechnologybiotechnologydrug-designfoodtechpharmaceuticalsanimal-healthoral-drugsmedical-cannabisdrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | formulex-pi.com/ |
|---|---|
| linkedin.com/company/1044256 |
Identifiers & details
| Former names | SoluBest |
|---|---|
| Founded | 2019-4 |
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | formulex-pi.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513125682 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2001-07-01 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2015 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | אינשטיין 18 נס ציונה |